Comparative genomics and epigenomics of aging
Comparative genomics and epigenomics of aging
批准号:
10399524
负责人:
Vadim N. Gladyshev
金额:
$41.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2024-04-30
关键词:
AddressAgeAgingAnimalsBalaenaBeaversBiologicalBiological MarkersBloodCell Culture TechniquesCellsChemicalsCollaborationsCultured CellsDNA DamageDNA MethylationDNA RepairDataData AnalysesData SetDevelopmentElementsEpigenetic ProcessEvolutionGamma RaysGene ExpressionGenesGenomeGenomicsGoalsHAS2 geneHyaluronidaseInterventionLeadLifeLinkLongevityMaintenanceMammalsModelingMole RatsMolecularMolecular ProfilingMusNaturePatternPhaseProcessReportingResourcesRodentSamplingSequence AnalysisShrewsSystemTestingTissuesTransgenic Miceage relatedbasechromatin remodelingcomparativecomparative genomicsdata frameworkdata visualizationepigenomicsgenome analysisgenome annotationgenome-widehealthspanimprovedinhibitorinsightmolecular markermouse modeloverexpressionsocialtooltraittranscriptometranscriptome sequencingwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY: The aging process can be naturally accelerated and decelerated during evolution leading to
significant diversity in lifespan among related species. Mammals represent a particularly convenient system to
examine this diversity at the molecular level, because these animals are characterized by a nearly hundred-fold
difference in lifespan and their tissues and cultured cells are readily available. Unbiased characterization of
genes and processes that are associated with natural changes in lifespan within mammals may lead to the
development of approaches that target the aging process and possibly delay it. We hypothesize that mammalian
lifespan is adjusted through a combination of common and lineage-specific processes and provide preliminary
data in support of this idea. In the ongoing phase of the PPG we generated exciting data that support our general
approach to lifespan control. We generated comprehensive molecular profiles across mammals, including
species of exceptional longevity. These datasets include RNAseq, metabolite profiling, and chemical element
profiling as well as the genomes of long-lived naked mole rat and beaver. We also generated a DNA methylation
clock for mice and found that it correctly reports the effects of longevity interventions. We propose to utilize these
tools and approaches to address, in close collaboration with other Projects and Cores, critical questions in our
understanding of natural control of mammalian lifespan. Specifically, we propose to examine: (1) Molecular
features underlying longevity in mammals. We will utilize the profiles we generated to identify molecular features
and their combinations, with a focus on gene expression and metabolites, linked with longevity, ultimately
building molecular signatures of long-lived species (with Core C). We will also carry out gene expression and
metabolite profiling analyses of beaverized SIRT6 mice (with Project 1 and Core B), naked mole rat HAS2
transgenic mice, and mice treated with hyaluronidase inhibitors (with Project 2 and Core B), providing critical
molecular insights into the mechanisms by which these genes promote longevity. (2) Genomics of long-lived
rodents. We will carry out comprehensive annotation of new, much improved assemblies of naked mole rat and
beaver genomes (with Core C), in turn providing critical resources for Projects, 1, 2 and 3. We will also focus on
the evolution of DNA repair and chromatin remodeling genes and characterization of gene loss and gain in these
species. (3) Applications of the epigenetic clock to mouse models of longevity. We have recently developed a
mouse DNA methylation clock, which we will apply to the animal and cell culture models examined in the PPG
(with Projects 1, 2, and 3, and Cores B and C). (4) Development and application of the naked mole rat epigenetic
clock. We will utilize naked mole rats differing in age (with Project 2 and Core B), quantify age-dependent patterns
of DNA methylation, and develop and apply a molecular marker of biological age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Profiling epigenetic age in single cells and in a high-throughput manner
-
批准号:10688326
-
项目类别:
-
资助金额:$31.05万
-
财政年份:2022
-
负责人:Vadim N. Gladyshev
-
依托单位:
Role of rare damaging mutations in aging
-
批准号:10224089
-
项目类别:
-
资助金额:$55.52万
-
财政年份:2020
-
负责人:Vadim N. Gladyshev
-
依托单位:
QUANTITATIVE ASSESSMENT OF BIOLOGICAL AGE AND ITS APPLICATIONS
-
批准号:10833859
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2020
-
负责人:Vadim N. Gladyshev
-
依托单位:
Role of rare damaging mutations in aging
-
批准号:10403519
-
项目类别:
-
资助金额:$55.52万
-
财政年份:2020
-
负责人:Vadim N. Gladyshev
-
依托单位:
QUANTITATIVE ASSESSMENT OF BIOLOGICAL AGE AND ITS APPLICATIONS
-
批准号:10425342
-
项目类别:
-
资助金额:$62.38万
-
财政年份:2020
-
负责人:Vadim N. Gladyshev
-
依托单位:
QUANTITATIVE ASSESSMENT OF BIOLOGICAL AGE AND ITS APPLICATIONS
-
批准号:10225348
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2020
-
负责人:Vadim N. Gladyshev
-
依托单位:
QUANTITATIVE ASSESSMENT OF BIOLOGICAL AGE AND ITS APPLICATIONS
-
批准号:10672456
-
项目类别:
-
资助金额:$67.54万
-
财政年份:2020
-
负责人:Vadim N. Gladyshev
-
依托单位:
Role of rare damaging mutations in aging
-
批准号:10669699
-
项目类别:
-
资助金额:$55.52万
-
财政年份:2020
-
负责人:Vadim N. Gladyshev
-
依托单位:
Unbiased identification of interventions that extend lifespan
-
批准号:10674697
-
项目类别:
-
资助金额:$68.03万
-
财政年份:2019
-
负责人:Vadim N. Gladyshev
-
依托单位:
Unbiased identification of interventions that extend lifespan
-
批准号:9790603
-
项目类别:
-
资助金额:$72.82万
-
财政年份:2019
-
负责人:Vadim N. Gladyshev
-
依托单位:
Unbiased identification of interventions that extend lifespan
-
批准号:10196931
-
项目类别:
-
资助金额:$70.58万
-
财政年份:2019
-
负责人:Vadim N. Gladyshev
-
依托单位:
Unbiased identification of interventions that extend lifespan
-
批准号:10407607
-
项目类别:
-
资助金额:$72.36万
-
财政年份:2019
-
负责人:Vadim N. Gladyshev
-
依托单位:
Unbiased identification of interventions that extend lifespan
-
批准号:10019456
-
项目类别:
-
资助金额:$67.24万
-
财政年份:2019
-
负责人:Vadim N. Gladyshev
-
依托单位:
Systems level understanding of selenoprotein biosynthesis
-
批准号:9891054
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2018
-
负责人:Vadim N. Gladyshev
-
依托单位:
Systems level understanding of selenoprotein biosynthesis
-
批准号:10392412
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2018
-
负责人:Vadim N. Gladyshev
-
依托单位:
Comparative genomics and epigenomics of aging
-
批准号:10620754
-
项目类别:
-
资助金额:$41.89万
-
财政年份:2014
-
负责人:Vadim N. Gladyshev
-
依托单位:
Comparative genomics and epigenomics of aging
-
批准号:10152480
-
项目类别:
-
资助金额:$41.9万
-
财政年份:2014
-
负责人:Vadim N. Gladyshev
-
依托单位:
Mechanisms of lifespan control
-
批准号:8738590
-
项目类别:
-
资助金额:$88.44万
-
财政年份:2013
-
负责人:Vadim N. Gladyshev
-
依托单位:
Mechanisms of lifespan control
-
批准号:8564159
-
项目类别:
-
资助金额:$88.23万
-
财政年份:2013
-
负责人:Vadim N. Gladyshev
-
依托单位:
REDOX BIOCHEMISTRY
-
批准号:8250451
-
项目类别:
-
资助金额:$19.37万
-
财政年份:2011
-
负责人:Vadim N. Gladyshev
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: